Fresenius Medical Care (ETR:FME) Hits New 12-Month High – Should You Buy?

Fresenius Medical Care AG (ETR:FME)’s share price reached a new 52-week high on Tuesday . The stock traded as high as €42.81 ($45.06) and last traded at €41.97 ($44.18), with a volume of 341750 shares. The stock had previously closed at €43.00 ($45.26).

Fresenius Medical Care Stock Performance

The stock has a market cap of $12.31 billion, a P/E ratio of 23.34, a PEG ratio of 0.42 and a beta of 0.86. The stock has a fifty day simple moving average of €38.28 and a 200-day simple moving average of €37.32. The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.